Stock comparison
Mettler-Toledo International
Vaxcyte
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
MTD
Mettler-Toledo International
Market cap
$22.29B
Sector
Healthcare
PCVX
Vaxcyte
Market cap
$6.83B
Sector
Healthcare
Overall winner
Mettler-Toledo International MTD
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | MTD | PCVX | Winner |
|---|---|---|---|
| Warren Buffett | 69B | 15F | MTD |
| Benjamin Graham | 65B | 46D | MTD |
| Philip Fisher |
Side-by-side metrics
| Metric | MTD | PCVX |
|---|---|---|
| Market cap | $22.29B | $6.83B |
| P/E (TTM) | 25.3x | - |
| EV/EBIT | 21.6x | - |
| ROIC (TTM) | 36.09% | -34.98% |
| Gross margin | 57.79% | 0.0% |
| Net margin | 21.4% | 0.0% |
| Revenue CAGR 5y | 2.01% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
MTD leads on
- ROIC (TTM)36.09%vs -34.98%+197%
- Debt / Equity-vs 0.0x+100%
- Gross margin57.79%vs 0.0%+100%
- Net margin21.4%vs 0.0%
More like PCVX
Related on invest-like
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.